A psychosocial model of a medical problem: Maternal phenylketonuria

S Shiloh1, S E Waisbren, H L Levy

  • 1Institute for Child Development, Sheba Medical Center, Tel-Hashomer, Israel.

Insights

Maternal phenylketonuria (PKU) management requires strict dietary adherence for offspring health. A new psychosocial model outlines four reproductive stages to improve patient coping and treatment success for women with PKU.

Area of Science:

  • Reproductive health
  • Metabolic disorders
  • Psychosocial adjustment

Background:

  • Maternal phenylketonuria (PKU) treatment involves a low phenylalanine diet to prevent adverse offspring outcomes.
  • Poor patient adherence to medical recommendations is a significant challenge in managing maternal PKU.
  • Understanding psychosocial factors is crucial for improving treatment adherence.

Purpose of the Study:

  • To present a psychosocial model for adjustment and coping in maternal PKU.
  • To define behavioral goals across four key reproductive stages for women with PKU.
  • To identify psychosocial factors influencing adherence to dietary management.

Main Methods:

  • Literature review on behaviors and psychosocial factors related to maternal PKU management.
  • Development of a four-stage psychosocial model for the reproductive years of women with PKU.
  • Analysis of factors contributing to success or failure in achieving behavioral goals at each stage.

Main Results:

  • The model identifies four distinct stages: pregnancy prevention, reproductive decision-making, diet initiation, and diet continuation.
  • Psychosocial factors influencing adherence were identified for each stage.
  • The framework provides insights into challenges and potential interventions for maternal PKU management.

Conclusions:

  • A structured psychosocial model can enhance understanding of maternal PKU management.
  • Targeted interventions addressing psychosocial factors at each reproductive stage may improve patient adherence.
  • This model offers a theoretical basis for practical clinical strategies in maternal PKU care.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.5K
Models of Health Promotion and Illness Prevention I01:25

Models of Health Promotion and Illness Prevention I

A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
2.8K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97